Lauren M. Sabella, Chief Commercial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 1,513 shares at $1.60 ($2K) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Scheduled sale ($2k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |
| ACOR | SELL | 2018-06-12 | $853K | — | Filing → |